# Nuclide record radiopharma-roadmap (roadmap). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/roadmaps/radiopharma-roadmap/>
  a schema:CreativeWork ;
  nuclide:kind "roadmap" ;
  schema:identifier "radiopharma-roadmap" ;
  schema:name "Radiopharmaceutical roadmap: iodine → lutetium → actinium"@en ;
  schema:description "The radiopharmaceutical roadmap runs eighty years from radioactive iodine for thyroid cancer to alpha-emitting drugs for prostate and neuroendocrine cancers, with isotope supply as the limiting factor."@en ;
  schema:url <https://nuclide.cc/roadmaps/radiopharma-roadmap/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa2107322> ;
  nuclide:related <https://nuclide.cc/isotopes/ga-68/>, <https://nuclide.cc/isotopes/ac-225/>, <https://nuclide.cc/isotopes/ra-223/>, <https://nuclide.cc/isotopes/pb-212/> ;
  nuclide:technologies <https://nuclide.cc/technologies/radioligand-therapy/>, <https://nuclide.cc/technologies/targeted-alpha-therapy/>, <https://nuclide.cc/technologies/psma-pet/>, <https://nuclide.cc/technologies/fapi-pet/>, <https://nuclide.cc/technologies/radioimmunotherapy/> .